Follow DNDi on LinkedInFollow DNDi on TwitterFollow DNDi on Facebook

Chagas Platform


Founded: 2009 in Uberaba, Brazil

To support its R&D activities on Chagas disease, DNDlaunched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The CCRP aims to facilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it will identify and review priority needs, work towards standardization of methodology to assess drug efficacy to treat T. cruzi infection, review alternatives for using current drugs approved (new schemes, doses, combination) and special scenarios (resistance).

Chagas Platform Map


Chagas Platform Newsletter

  • Newsletter n°3, April 2013 [PDF]



Tags: Chagas disease
Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site
is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License